Brief: Agenus Says Received Notice From Bristol Myers Squibb, It Is Returning Agen1777

Agenus

02/08/2024 21:27

Aug 2 (Reuters) - Agenus Inc  AGEN.O :
    * AGENUS INC -  ON JULY 30 RECEIVED NOTICE FROM BRISTOL
MYERS
SQUIBB,IT IS RETURNING AGEN1777 BACK TO AGENUS
    * AGENUS INC -  ON JULY 30, RECEIVED NOTICE FROM BMS THAT IT
IS
VOLUNTARILY TERMINATING BMS LICENSE AGREEMENT, EFFECTIVE AS OF
JANUARY 26, 2025
    * AGENUS INC - WILL NOT INCUR ANY EARLY TERMINATION
PENALTIES AS A
RESULT OF TERMINATION
    * AGENUS INC - WILL HAVE RIGHT TO CONTINUE DEVELOPMENT OR
ENTER A
SUBSEQUENT LICENSE IN FUTURE
    * AGENUS INC - BMS WILL ASSIGN TO CO ALL REGULATORY
REGISTRATIONS,
APPLICATIONS, AUTHORIZATIONS, APPROVALS THAT BMS HOLDS IN
CONNECTION WITH AGEN1777

Source text for Eikon:  ID:n0000950170-24-089932 
Further company coverage:  AGEN.O 

 ((Reuters.Briefs@thomsonreuters.com;))